A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions

NCT00865059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Gabapentin 800 mg Tablets, single dose
DRUG: NEURONTIN® 800 mg Tablets, single dose

Sponsor

Actavis Inc.